Literature DB >> 21070456

A double-blind, randomized, placebo-controlled health-outcomes survey of the effect of botulinum toxin type a injections on quality of life and self-esteem.

Steven H Dayan1, John P Arkins, Amit B Patel, Thomas J Gal.   

Abstract

BACKGROUND: Although studies show that botulinum toxin type A (BoNTA) can positively influence one's first impression, little research has been conducted to measure the effect that BoNTA has on mental well-being.
OBJECTIVE: To determine the effects that BoNTA injections for the treatment of facial wrinkles had on quality of life (QOL) and self-esteem. METHODS AND MATERIALS: One hundred participants received treatment with BoNTA or placebo saline in this double-blind randomized placebo-controlled survey. All participants completed a health outcomes survey consisting of Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form and Heatherton and Polivy State Self-Esteem measurements before injection and 2 weeks and 3 months after injection.
RESULTS: Statistically significant improvements (p<.05) in participants treated with BoNTA were observed in answers to QOL questions regarding physical health, mood, household activities, overall life satisfaction, body satisfaction, self-consciousness, intellect, self-worth, appearance, comprehension, weight satisfaction, attractiveness, and sense of well-being. Increases in overall self-esteem and appearance-, social-, and performance-related self-esteem were observed in participants treated with BoNTA.
CONCLUSION: Our findings showed that BoNTA injections result in improvements in QOL and self-esteem. In addition, BoNTA-naïve participants demonstrate greater improvements in QOL and self-esteem than participants previously exposed to BoNTA. Moreover, BoNTA-familiar participants demonstrated sustained improvement in QOL and self-esteem relative to BoNTA-naïve participants, even when injected with placebo.
© 2010 by the American Society for Dermatologic Surgery, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21070456     DOI: 10.1111/j.1524-4725.2010.01795.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  16 in total

1.  Safety and Efficacy of Facial Rejuvenation with Small Gel Particle Hyaluronic Acid with Lidocaine and AbobotulinumtoxinA in Post-Chemotherapy Patients: A Phase IV Investigator-initiated Study.

Authors:  Ava Shamban
Journal:  J Clin Aesthet Dermatol       Date:  2014-01

2.  A Single-blind, Split-face, Randomized, Pilot Study Comparing the Effects of Intradermal and Intramuscular Injection of Two Commercially Available Botulinum Toxin A Formulas to Reduce Signs of Facial Aging.

Authors:  Priya Sapra; Shantel Demay; Sheetal Sapra; Julie Khanna; Kelli Mraud; Jennifer Bonadonna
Journal:  J Clin Aesthet Dermatol       Date:  2017-02-01

3.  Assessing Improvement of Facial Appearance and Quality of Life after Minimally-Invasive Cosmetic Dermatology Procedures Using the FACE-Q Scales.

Authors:  Brian P Hibler; Jonathan Schwitzer; Anthony M Rossi
Journal:  J Drugs Dermatol       Date:  2016-01       Impact factor: 2.114

4.  Impact of botulinum toxin a on the quality of life of subjects following treatment of facial lines.

Authors:  Ravi Jandhyala
Journal:  J Clin Aesthet Dermatol       Date:  2013-09

5.  [Body experience and self-esteem after minimally invasive skin rejuvenation : Study of female patients using botulinum toxin A and/or dermal fillers].

Authors:  D Scharschmidt; S Preiß; E Brähler; T Fischer; A Borkenhagen
Journal:  Hautarzt       Date:  2017-12       Impact factor: 0.751

6.  Impact of Minimally Invasive Aesthetic Procedures on the Psychological and Social Dimensions of Health.

Authors:  Darren J McKeown
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-04-28

7.  A Multicenter, Single-Blind Randomized, Controlled Study of a Volumizing Hyaluronic Acid Filler for Midface Volume Deficit: Patient-Reported Outcomes at 2 Years.

Authors:  Julius Few; Sue Ellen Cox; Deepali Paradkar-Mitragotri; Diane K Murphy
Journal:  Aesthet Surg J       Date:  2015-05-11       Impact factor: 4.283

8.  Attitudes, Concerns, and Expectations of Consumers of Aesthetic Medicine and Surgery During the COVID-19 Outbreak: An Italian Online Survey.

Authors:  Fabrizio Melfa; Bruno Bovani; Pierfrancesco Cirillo; Matteo Tretti Clementoni; Alessandro Gennai
Journal:  Aesthet Surg J Open Forum       Date:  2020-08-13

9.  Botulinum toxin type A for facial wrinkles.

Authors:  Cristina Pires Camargo; Jun Xia; Caroline S Costa; Rolf Gemperli; Maria Dc Tatini; Max K Bulsara; Rachel Riera
Journal:  Cochrane Database Syst Rev       Date:  2021-07-05

10.  A Multicenter Study to Evaluate Subject Satisfaction With Two Treatments of AbobotulinumtoxinA a Year in the Glabellar Lines.

Authors:  Joel Schlessinger; Joel L Cohen; Ava Shamban; Carolyn Jacob; Kian Karimi; Corey Maas; Vanessa Lane; Sarah Coquis-Knezek; Matthew Meckfessel
Journal:  Dermatol Surg       Date:  2021-04-01       Impact factor: 2.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.